The DOI matches its Crossref record.
Treatment for Chronic Prostatitis/ Chronic Pelvic Pain Syndrome: Levofloxacin, Doxazosin and Their Combination
Abstract
Introduction: We performed a prospective, randomized study to examine the efficacies of levofloxacin and doxazosin alone and as a combination therapy in patients with National Institutes of Health (NIH) category III chronic prostatitis/chronic pelvic pain syndrome. Patients and Methods: Men with a NIH diagnosis of category III chronic prostatitis/chronic pelvic pain syndrome and who had experienced pelvic pain for more than 3 months during the last 6 months were enrolled. All patients underwent treatment for 6 weeks. The patients were assessed at baseline and after 2 and 6 weeks by using the NIH Chronic Prostatitis Symptom Index. Eighty-one men (average age 40.1 years) were randomized to either the levofloxacin group (n = 26), the doxazosin group (n = 26), or the combination group (n = 29). Results: The average baseline NIH Chronic Prostatitis Symptom Index total scores were 22.6, 22.4, and 24.1, respectively. At 6 weeks, the total scores were 11.2 (response rate 50.3%), 17.7 (response rate 21.1%), and 13.1 (response rate 45.6%), respectively. The levofloxacin group showed a higher response rate than the doxazosin group, not at 2 weeks but at 6 weeks (p < 0.001). Conclusions: For a 6-week short-term treatment levofloxacin is more effective than doxazosin for chronic prostatitis/chronic pelvic pain syndrome. In addition, levofloxacin monotherapy was also more effective when compared with the combination therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similar results were obtained in a comparison of doxazosin, levofloxacin and a combination of both, with the multimodal arm failing to provide any additional benefit over monotherapy 84.”
From Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline (2015) · cites this paper as [84]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 19
- 10.1016%2FS0022-5347%2801%2963564-X · DOI · Paper page
- 10.1016%2FS0090-4295%2897%2900308-7 · doi:10.1016/s0090-4295(97)00308-7
- 10.1016%2FS0090-4295%2898%2900297-0 · DOI
- 10.1016%2FS0090-4295%2897%2900336-1 · doi:10.1016/s0090-4295(97)00336-1
- 10.1046%2Fj.1464-410X.2000.00836.x · DOI · Paper page
- 10.1016%2FS0022-5347%2801%2966359-6 · DOI · Paper page
- 10.1016%2FS0022-5347%2805%2964686-1 · DOI · Paper page
- 10.1111%2Fj.1442-2042.1998.tb00597.x · doi:10.1111/j.1442-2042.1998.tb00597.x
- 10.1016%2FS0022-5347%2805%2963960-2 · doi:10.1016/s0022-5347(05)63960-2
- 10.1097%2F01.ju.0000117811.40279.19 · DOI
- 10.1016%2FS0090-4295%2803%2900466-7 · DOI · Paper page
- 10.1016%2FS0090-4295%2803%2900583-1 · DOI
- 10.1007%2FBF01643680 · DOI
- 10.1002%2Fpros.2990230204 · DOI
- 10.1159%2F000029906 · DOI
- 10.1016%2FS0022-5347%2805%2966344-6 · DOI
- 10.1016%2FS0090-4295%2898%2900390-2 · DOI · Paper page
- 10.1159%2F000239480 · doi:10.1159/000239480
- 10.1159%2F000019784 · doi:10.1159/000019784
Cited by
Rees, J., Abrahams, M., Doble, A., Cooper, A., & the Prostatitis Expert Reference Group (PERG) (2015) · BJU International · doi:10.1111/bju.13101 · Cited by 371
Metadata
- Authors
- Jeong, C. W., Lim, D. J., Son, H., Lee, S. E., & Jeong, H.
- Venue
- Urologia Internationalis
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 80
- Issue
- 2
- Pages
- 157-161
- ISSN
- 0042-1138
- 1423-0399
- Cited by
- 26
- References
- 0
- Language
- en
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment for Chronic Prostatitis/ Chronic Pelvic Pain Syndrome: Levofloxacin, Doxazosin and Their Combination. https://app.cochat.ai/papers/10.1159/000112606
- The paper
- Jeong, C. W., Lim, D. J., Son, H., Lee, S. E., & Jeong, H. (2008). Treatment for Chronic Prostatitis/ Chronic Pelvic Pain Syndrome: Levofloxacin, Doxazosin and Their Combination. Urologia Internationalis. https://doi.org/10.1159/000112606
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.